The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
I sent in this question for the December IMC meeting: Are you investigating genetic typing (e.g. using AI) to determine which cancers are likely to be best treated with pre|CISION drugs and which side effects are likely for which patients?
This was question 5. Answer was: "We have designed a very data rich Phase 1 study that will measure a number of exploratory biomarkers. These data will be presented in 2024 when new intellectual property has been protected."
The AVA6000 trial protocol has not been updated since 11 April last year. AS didn't answer my question about whether Avacta is obliged to maintain the entry up to date but it seems there is no obligation on companies to keep their entries current.
Not the first time I've seen ambulance chasers coming out to feed on bad news...
https://www.marketwatch.com/press-release/investigation-alert-the-schall-law-firm-announces-it-is-investigating-claims-against-verve-therapeutics-inc-and-encourages-investors-with-losses-to-contact-the-firm-40de923a?mod=mw_quote_news_seemore
" LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verve Therapeutics, Inc. ("Verve" or "the Company") (NASDAQ: VERV) for violations of the securities laws.
"The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Verve is the subject of an article published by Bloomberg on April 2, 2024. According to the article, the Company "cited safety concerns for pausing enrollment in a study of its gene-editing treatment for people with high cholesterol, delivering a setback to the promising new field of medicine." Based on this news, shares of Verve fell by more than 40% in morning trading on the same day.
"If you are a shareholder who suffered a loss, click here to participate."
Avacta, on past events, would be like lambs to the slaughter.
22 April (approx)
Oh dear, oh dear.
GoSushi, name me a company, successful or otherwise, where "adverse and unexpected events have [NOT] happened in the history of the company."
Wyndrum knows diddly-squat about the pharma industry, just as he knows the square root of f'all about helium mining, ship building or whatever other industry he's gambled in. So do you really think his talking points are worth anything?
"The comments below the article are very sad"
A mixture of ignorance and agenda, mainly from people in the USA, such as "There is no money to be made in curing cancer. The money is in high dollar chemo treatments, which produce their own various side effects, which generate additional revenue." Talk about putting the cart before the horse!!!
A sensible (realistic) comment from the 'Welsh border, United Kingdom,1 day ago' "That's what chemo does. It's horrific. It's not a miracle cure, it keeps you going for longer than you would of had if you can put up with what it does to your body."
Wyndrum is a troll. A very tedious troll. Just ignore, fiter or report.
"They might just be covering their IP bases without planning to develop yet."
The IP life starts ticking as soon as the patent is filed. You either patent to protect something you're putting into development or you patent to queer the pitch for others who may want to patent in that area (by publishing prior art to negate the novelty) - or you patent because a competitor is, or may be, about to patent.
Yeah but Thompi, that was before AS got his speeding ticket.
Another special kind of idiot. If you're going to try your hand at FUD at least do SOME research.
Poster presentation is on 9 April.
Congratulations 5RINGS, you have demonstratd the art of stupidity in spuds with added neediness. Well done you. Maybe ask your carer nicely if SHE will ask for a shareholder tour for you if you can't overcome your natural reticence.
Apparently he was clutching a share certificate and demanding at the top of his voice that he be allowed in to see how they make the food.
You really are a tedious twat Eggy.
5RINGS, are you innately stupid or did it take practice?
Do you think CC organised and executed this independently of the GCD? Busy lady. What else could she take on?
@Thornogson's "Just like the ease that they we're able to modify the Affimers to detect new Covid variants with the LFD?
"Just saying. The board was full of it. Then it didn't happen, any of it.
"It's all just so much talk and 'hot air' until it actually happens."
Anyone who is not aware of the four facts Eggy steamrollered to make this totally fabricated argument (FUD) should filter the account now or run the risk of being scared into selling through sheer ignorance.
1. Dx and Tx are completely different industries with different timescales, margins, regulatory control, etc, etc.
2. It was the antibody that failed, not the Affimer.
3. Given the time required to develop a new product and get approval to sell, the peak Covid opportunity was over.
4. No British companies could compete on cost and quantity with the cheap Chinese tests the Tory government was paying hand over fist to have imported, no matter the quality of the tests.
@5RINGS' "Something fishy is going on. Shareholders need to be let into the laboratories to see for themselves. I'm not convinced about the work going on here."
🤣🤣🤣🤣🤣
Probably the most idiotic comment I've ever read on here. Really this standard of FUD...🙄
@MelvinAFC, if AB is making up the financial stuff, what's the CFO doing? Why do you ascribe everything to AB, idiot.
No one should forget that HurstBot is permanently set to Moron.